The FirstTake Podcast – A tale of two COVID-19 vaccines
FirstTake on Pharma - Pharma News and Analysis Podcast
English - July 29, 2021 22:00 - 30 minutes - 21.5 MB - ★★★★★ - 2 ratingsScience pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Next Episode: The FirstTake Podcast – A landmark approval in lupus
FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss Pfizer’s projected COVID-19 vaccine revenues for 2021 and whether clinical data validates the commercial dominance of this product over AstraZeneca’s competing vaccine, look at Keytruda’s increasingly compelling profile as a treatment for early-stage and advanced triple-negative breast cancer (TNBC) and put Amgen’s acquisition of Teneobio under the spotlight.